DEC 17, 2018 4:05 PM PST

Alzheimer Preventing Drug Could Work Like A Vaccine

WRITTEN BY: Nouran Amin

Researchers at UT Southwestern believe that a protein called ApoE is the primary factor in late-onset Alzheimer's disease. Such conclusion has to inspired the development of a potential ‘vaccine’ drug that may be administered before age 40 for the potential prevention of the disease in about 50 to 80 percent of at-risk adults.

Learn more about Alzheimer Disease:

ApoE stands for Apolipoprotein E which carries fatty substances known as lipids and cholesterol around the brain playing an important role in repair mechanisms. Essentially, a particular subtype of the protein--ApoE4—works by promoting the accumulation of the b-amyloid protein that causes plaques seen in the brains of Alzheimer patients.

"If we can negate the ApoE4 process early, we may be able to prevent late-onset Alzheimer's altogether for many people so that they will never get sick," explains Dr. Joachim Herz, UT Southwestern molecular biologist and Alzheimer's expert.

The ApoE4 protein not only increases plaque formation in the brain but has been confirmed to suppress and trap synaptic receptors within intracellular vesicles. Researchers believe that reversing the effects of ApoE4 via pharmacological and genetic inhibition of a certain protein, NHE6, which is involved in the acidity of endosomal vesicles—will likely prevent the late-onset of Alzheimer’s disease.

A potential new drug targeting the effects of ApoE4 protein could work like a ‘vaccine’ in the prevention of Alzheimer’s disease in at-risk individuals.

Credit: UT Southwestern Medical Center

This novel therapeutic approach has been successful in mice. "The beauty of NHE6 inhibitors is that these are small molecules that can be produced inexpensively and thus made widely available, in contrast to the more elaborate antibody-based therapies that are currently being evaluated in clinical trials. A simple pill could someday neutralize the risk of late-onset Alzheimer's disease just as readily available statins are able to reduce the risk of cardiovascular disease," Dr. Herz said. "Our approach in this study was to stop the overall degeneration process earlier; that is, before the formation of these aggregates.”

Source: UT Southwestern Medical Center

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
MAY 13, 2020
Drug Discovery & Development
Fecal Transplant Helps Fight off Antibiotic Resistance
MAY 13, 2020
Fecal Transplant Helps Fight off Antibiotic Resistance
Fecal transplants work by transporting fecal matter from healthy donors to those who are less healthy. Now, a study has ...
MAY 18, 2020
Cancer
How do Ohnologs affect Cancer?
MAY 18, 2020
How do Ohnologs affect Cancer?
Genetics can be complicated to say the least. Sometimes it can be as simple as a single mutation in one gene that causes ...
MAY 25, 2020
Cancer
Using Transcription Factors to Predict Bladder Cancer Prognosis
MAY 25, 2020
Using Transcription Factors to Predict Bladder Cancer Prognosis
Bladder cancer is a rare form of cancer, with a relatively high recovery rate. Recurrence is still an issue; however, wi ...
MAY 22, 2020
Drug Discovery & Development
Evaluating a Popular Diabetic Drug
MAY 22, 2020
Evaluating a Popular Diabetic Drug
A study by researchers at UT Southwestern study shows that a previous drug for Type 2 diabetes may be effective when pai ...
JUN 18, 2020
Drug Discovery & Development
FDA Cancels Emergency Approval for Hydroxychloroquine
JUN 18, 2020
FDA Cancels Emergency Approval for Hydroxychloroquine
The US Food and Drug Administration (FDA) has decided to cancel emergency use authorization for Hydroxychloroquine and C ...
JUL 02, 2020
Drug Discovery & Development
Common Asthma Drug Could Treat Alzheimer's
JUL 02, 2020
Common Asthma Drug Could Treat Alzheimer's
Researchers from Lancaster University, England, have found that Salbutamol, a medication commonly used to treat asthma, ...
Loading Comments...